Petros Pharmaceuticals Inc (PTPI) — Financial Flexibility Index

Latest as of March 2025: -0.05x

Petros Pharmaceuticals Inc (PTPI) has a Financial Flexibility Index of -0.05x as of March 2025. Free cash flow of $-1.49 Million (operating CF $-1.49 Million minus capex $0.00) represents 0% of total liabilities ($27.19 Million). Also explore PTPI net asset momentum to track the company's year-over-year net asset growth rate.

Financial Flexibility Index

-0.05x
Free Cash Flow / Total Liabilities

Free Cash Flow

$-1.49 Million
Operating CF − Capex

Total Liabilities

$27.19 Million
USD

Capital Expenditures

$0.00
USD

Petros Pharmaceuticals Inc Financial Flexibility Index (2018–2024)

Historical Financial Flexibility Index trend for Petros Pharmaceuticals Inc across 7 annual periods. Check PTPI strategic asset allocation to assess the company's strategic physical and investment asset allocation.

Annual Financial Flexibility Index for Petros Pharmaceuticals Inc (2018–2024)

Year-by-year free cash flow to debt coverage for Petros Pharmaceuticals Inc. For the full company profile including market capitalisation, see Petros Pharmaceuticals Inc (PTPI) total market value.

Year Flexibility Index Free Cash Flow (USD) Operating CF Total Liabilities YoY Change
2024 -0.14x $-2.58 Million $-2.60 Million $18.10 Million ▲ +60.2%
2023 -0.36x $-7.63 Million $-7.63 Million $21.32 Million ▲ +56.1%
2022 -0.81x $-12.80 Million $-12.80 Million $15.72 Million ▼ -118.6%
2021 -0.37x $-11.86 Million $-11.86 Million $31.85 Million ▼ -27.5%
2020 -0.29x $-15.30 Million $-15.31 Million $52.38 Million ▼ -664.7%
2019 0.05x $2.60 Million $2.53 Million $50.35 Million ▼ -64.2%
2018 0.14x $9.90 Million $8.02 Million $68.57 Million
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities